name:-0.099057197570801
name:-0.038653135299683
name:-0.022071123123169
Song; Xiaohong Patent Filings

Song; Xiaohong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Song; Xiaohong.The latest application filed is for "macrocyclic mcl-1 inhibitors and methods of use".

Company Profile
20.44.80
  • Song; Xiaohong - Beijing CN
  • Song; Xiaohong - Grayslake IL
  • Song; Xiaohong - Beijing 1 CN
  • Song; Xiaohong - Shanghai N/A CN
  • Song; Xiaohong - Shanghai City CN
  • Song; Xiaohong - Gurnee IL
  • Song; Xiaohong - Gunree IL
  • Song; Xiaohong - Park City IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Recombinant human replication-deficient adenovirus comprising a modified nucleic acid encoding the Marburg virus envelope glycoprotein
Grant 11,453,704 - Chen , et al. September 27, 2
2022-09-27
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20220259226 - Braje; Wilfried ;   et al.
2022-08-18
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210346369 - WANG; Le ;   et al.
2021-11-11
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20210292339 - BRAJE; Wilfried ;   et al.
2021-09-23
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210228565 - Wang; Le ;   et al.
2021-07-29
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210221789 - Bruncko; Milan ;   et al.
2021-07-22
Marburg Virus Vaccine With Human Replication-deficient Adenovirus As Vector
App 20200392188 - Chen; Wei ;   et al.
2020-12-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200345717 - WANG; Le ;   et al.
2020-11-05
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200325153 - Judd; Andrew S. ;   et al.
2020-10-15
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20200255451 - Kind Code
2020-08-13
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200253954 - Kind Code
2020-08-13
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20200246460 - Kind Code
2020-08-06
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors
App 20200246323 - Kind Code
2020-08-06
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
App 20200239553 - Ackler; Scott L. ;   et al.
2020-07-30
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20200239494 - BRAJE; Wilfried ;   et al.
2020-07-30
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200231566 - Bruncko; Milan ;   et al.
2020-07-23
Macrocyclic MCL-1 inhibitors and methods of use
Grant 10,676,485 - Judd , et al.
2020-06-09
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200010480 - Brady; Patrick B. ;   et al.
2020-01-09
Anti-cd98 Antibodies And Antibody Drug Conjugates
App 20200002432 - Benatuil; Lorenzo ;   et al.
2020-01-02
Anti-b7-h3 Antibodies And Antibody Drug Conjugates
App 20200002421 - Benatuil; Lorenzo ;   et al.
2020-01-02
Anti-egfr Antibody Drug Conjugates
App 20190153107 - Boghaert; Erwin R. ;   et al.
2019-05-23
Macrocyclic MCL-1 inhibitors and methods of use
App 20190144465 - Judd; Andrew S. ;   et al.
2019-05-16
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20190142941 - Ackler; Scott L. ;   et al.
2019-05-16
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20190119247 - Bruncko; Milan ;   et al.
2019-04-25
Macrocyclic MCL-1 inhibitors and methods of use
App 20190055264 - Brady; Patrick B. ;   et al.
2019-02-21
Ebola virus disease vaccine taking human replication deficient adenovirus as vector
Grant 10,172,932 - Chen , et al. J
2019-01-08
Ebola Virus Disease Vaccine Taking Human Replication Deficient Adenovirus As Vector
App 20180264100 - Chen; Wei ;   et al.
2018-09-20
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180251426 - Bruncko; Milan ;   et al.
2018-09-06
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180221363 - WANG; Le ;   et al.
2018-08-09
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180140595 - Wang; Le ;   et al.
2018-05-24
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,877,958 - Wang , et al. January 30, 2
2018-01-30
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,844,547 - Wang , et al. December 19, 2
2017-12-19
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors
Grant 9,796,708 - Tong , et al. October 24, 2
2017-10-24
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20170296531 - Wang; Le ;   et al.
2017-10-19
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors
App 20170182179 - Ackler; Scott L. ;   et al.
2017-06-29
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20170158666 - Bruncko; Milan ;   et al.
2017-06-08
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20160339117 - Ackler; Scott L. ;   et al.
2016-11-24
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160206611 - Wang; Le ;   et al.
2016-07-21
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
App 20160158377 - Ackler; Scott L. ;   et al.
2016-06-09
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160158218 - Wang; Le ;   et al.
2016-06-09
7-substituted indole Mcl-1 inhibitors
Grant 9,359,296 - Wang , et al. June 7, 2
2016-06-07
Tetracyclic CDK9 kinase inhibitors
Grant 9,328,112 - Frey , et al. May 3, 2
2016-05-03
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,303,025 - Bruncko , et al. April 5, 2
2016-04-05
Pyrrolo [2,3-b] Pyridine Cdk9 Kinase Inhibitors
App 20160060257 - Tong; Yunsong ;   et al.
2016-03-03
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,266,877 - Wang , et al. February 23, 2
2016-02-23
Plasma processing apparatus
Grant 9,271,384 - Chen , et al. February 23, 2
2016-02-23
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,227,963 - Wang , et al. January 5, 2
2016-01-05
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150329541 - Bruncko; Milan ;   et al.
2015-11-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,174,982 - Bruncko , et al. November 3, 2
2015-11-03
7-substituted Indole Mcl-1 Inhibitors
App 20150284328 - Wang; Xilu ;   et al.
2015-10-08
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,125,913 - Bruncko , et al. September 8, 2
2015-09-08
Tetracyclic Cdk9 Kinase Inhibitors
App 20150218165 - Frey; Robin ;   et al.
2015-08-06
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,072,748 - Bruncko , et al. July 7, 2
2015-07-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150183775 - BRUNCKO; Milan ;   et al.
2015-07-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150152097 - Wang; Le ;   et al.
2015-06-04
Apoptosis promoters
Grant 9,045,444 - Ding , et al. June 2, 2
2015-06-02
7-substituted indole Mcl-1 inhibitors
Grant 9,035,047 - Wang , et al. May 19, 2
2015-05-19
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150072978 - Wang; Le ;   et al.
2015-03-12
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,940,737 - Wang , et al. January 27, 2
2015-01-27
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,889,675 - Wang , et al. November 18, 2
2014-11-18
1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives
Grant 8,853,209 - Song , et al. October 7, 2
2014-10-07
Apoptosis Promoters
App 20140187531 - Bruncko; Milan ;   et al.
2014-07-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140113910 - Bruncko; Milan ;   et al.
2014-04-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140107119 - Bruncko; Milan ;   et al.
2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140094471 - Bruncko; Milan ;   et al.
2014-04-03
Apoptosis promoters
Grant 8,686,136 - Bruncko , et al. April 1, 2
2014-04-01
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140088106 - Bruncko; Milan ;   et al.
2014-03-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140057890 - Bruncko; Milan ;   et al.
2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140057889 - Bruncko; Milan ;   et al.
2014-02-27
7-substituted Indole Mcl-1 Inhibitors
App 20140051683 - WANG; Xilu ;   et al.
2014-02-20
Apoptosis promoters
Grant 8,614,318 - Bruncko , et al. December 24, 2
2013-12-24
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 8,586,754 - Bruncko , et al. November 19, 2
2013-11-19
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 8,563,735 - Bruncko , et al. October 22, 2
2013-10-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130267534 - Bruncko; Milan ;   et al.
2013-10-10
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130267514 - Bruncko; Milan ;   et al.
2013-10-10
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,546,399 - Bruncko , et al. October 1, 2
2013-10-01
Plasma Processing Apparatus
App 20130249399 - Chen; Jinyuan ;   et al.
2013-09-26
Apoptosis Promoters
App 20130190488 - Bruncko; Milan ;   et al.
2013-07-25
7-substituted indole MCL-1 inhibitors
Grant 8,445,679 - Wang , et al. May 21, 2
2013-05-21
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,426,422 - Hexamer , et al. April 23, 2
2013-04-23
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130096120 - WANG; LE ;   et al.
2013-04-18
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130096121 - Wang; Le ;   et al.
2013-04-18
Apoptosis promoters
Grant 8,354,404 - Bruncko , et al. January 15, 2
2013-01-15
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20120190688 - Bruncko; Milan ;   et al.
2012-07-26
Apoptosis promoters
Grant 8,173,811 - Bruncko , et al. May 8, 2
2012-05-08
Apoptosis promoters
Grant 8,084,607 - Bruncko , et al. December 27, 2
2011-12-27
7-nonsubstituted Indole Mcl-1 Inhibitors
App 20110263599 - Song; Xiaohong ;   et al.
2011-10-27
Apoptosis Promoters
App 20110256129 - Bruncko; Milan ;   et al.
2011-10-20
1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives
Grant 7,981,888 - Song , et al. July 19, 2
2011-07-19
Apoptosis promoters
Grant 7,973,161 - Bruncko , et al. July 5, 2
2011-07-05
Apoptosis Promoters
App 20110144112 - Bruncko; Milan ;   et al.
2011-06-16
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20110124628 - Bruncko; Milan ;   et al.
2011-05-26
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100305122 - Bruncko; Milan ;   et al.
2010-12-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100298323 - Bruncko; Milan ;   et al.
2010-11-25
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20100298321 - Bruncko; Milan ;   et al.
2010-11-25
Apoptosis promoters
App 20100240715 - Bruncko; Milan ;   et al.
2010-09-23
Apoptosis promoters
Grant 7,767,684 - Bruncko , et al. August 3, 2
2010-08-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100184750 - Hexamer; Laura A. ;   et al.
2010-07-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100160322 - Bruncko; Milan ;   et al.
2010-06-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20100152183 - Bruncko; Milan ;   et al.
2010-06-17
Apoptosis Promoters
App 20100022773 - Bruncko; Milan ;   et al.
2010-01-28
Apoptosis promoters
Grant 7,642,260 - Bruncko , et al. January 5, 2
2010-01-05
7-nonsubstituted Indole Mcl-1 Inhibitors
App 20090124616 - Song; Xiaohong ;   et al.
2009-05-14
7-substituted Indole Mcl-1 Inhibitors
App 20090054402 - Wang; Xilu ;   et al.
2009-02-26
Heat-shock protein binders
App 20070105862 - Bruncko; Milan ;   et al.
2007-05-10
Apoptosis promoters
App 20070072860 - Bruncko; Milan ;   et al.
2007-03-29
Apoptosis promoters
App 20070015787 - Bruncko; Milan ;   et al.
2007-01-18
Apoptosis promoters
App 20060258657 - Bruncko; Milan ;   et al.
2006-11-16
Apoptosis promoters
App 20060128706 - Bruncko; Milan ;   et al.
2006-06-15
N-acylsulfonamide apoptosis promoters
App 20050159427 - Bruncko, Milan ;   et al.
2005-07-21
Kinase inhibitors
Grant 6,831,175 - Li , et al. December 14, 2
2004-12-14
Kinase inhibitors
App 20030199511 - Li, Qun ;   et al.
2003-10-23
Kinase inhibitors
App 20030187026 - Li, Qun ;   et al.
2003-10-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed